Pay in 4 interest-free payments of $5.01 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
Researched applications In the published preclinical and clinical literature the effects of AOD-9604 are documented in the following areas: Obesity , Phase 2b failure (2007), but a complementary mechanism in combination protocols Lipolysis in animal models , robustly demonstrated (Heffernan 2001, Ng 2009) Inhibition of lipogenesis , demonstrated in hepatocytes and adipocytes Osteoarthritis and cartilage regeneration , emerging Phase 1/2 data (mLuna Pharmaceuticals 2018+) Tendinopathy , preclinical models Age-related sarcopenia (cachexia) , exploratory plans Lipodystrophy , preclinical data in animal models Hyperlipidemia , secondary endpoints in Phase 2 trials Science & studies 4.1 Key publications Heffernan M., Summers R.J., Thorburn A., et al
The school and the student-athlete shall be held accountable for all substances within the banned-drug class regardless of whether they have been specifically identified
[DOI] [PubMed] [Google Scholar] 36.Oteo-Alvaro A, Moreno E
It is widely used in regenerative settings because it supports tissue repair across multiple systems, particularly connective tissue
US$ 21.08
US$ 25.67
US$ 26.60